Nucleoside reverse transcriptase inhibitor active pharmaceutical ingredient acquired by antiviral drug manufacturers for HIV treatment regimens. Incorporated into combination tablets in virology-focused production sites. Global suppliers facilitate procurement for generic producers in emerging markets and established pharmaceutical hubs.